Our experience supporting a leading infliximab biosimilar brand has given us insight into the unique challenges involved in safeguarding an established biosimilar against other biosimilar competitors.

We understand your biosimilar's situation

Critical success factor

Retain market share through experience and heritage.

The challenges

  • Standing out among multiple biosimilar competitors
  • Communicating  real-world evidence to  increase HCP confidence
  • Leveraging the experience of the company

The key questions

  • How can you differentiate your product beyond price?
  • How can you support patients and HCPs?
  • Which product attributes should you highlight to providers, patients and payers?
  • What added value activities will support brand differentiation?

We can help you achieve your critical success factors

Impact case examples

Here are just a few examples of how we have supported biosimilar brands with retaining market share in the face of emerging competition:

  • Infographic and speaker slides communicating real-world evidence and value-added services

  • Compelling payer value proposition highlighting the company's heritage and biosimilar commitment

  • Differentiating support materials, like patient support programs and switch initiatives

  • Annual meetings presented by world-class faculty to reinforce the company’s position as a biosimilar leader

Whatever your market scenario, our team is here to support you with addressing the unique challenges facing your biosimilar brand.

Not defending an established biosimilar right now?

Launching and establishing a biosimilar

Market scenarios: launching and establishing a biosimilar

Marketing a portfolio of therapies

Market scenarios: the portfolio approach

Or return to the biosimilars home page

Impact: biosimilar specialists

Accelerating the uptake of your biosimilar